Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mindfulness added to prophylaxis for chronic migraine and medication overuse
NCT03671681Phase 4Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Nov 2018
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic migraine and medication overuse headache (MOH), sponsored by Carlo Besta Neurological Institute. Primary endpoint: Headache frequency reduction at 12 months. Started Nov 2018; status: completed.
02
Conditions
chronic migrainemedication overuse headache (MOH)
Beyond the preview
Go deeper on NCT03671681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671681.